| 0 | 💬 0 |
Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-08-03 | #vaccination #clinical trial #hpv #immunogenicity #efficacy |